People lost up to 85 pounds on Lilly’s experimental weight loss drug, company says
Eli Lilly's experimental weight loss drug, retatrutide, has shown promising results in a late-stage clinical trial, with participants losing up to 85 pounds. The weight loss achieved is comparable to that of bariatric surgery, marking a significant milestone in medication trials. The company plans to seek FDA approval for the drug later this year.
- ▪Retatrutide helped participants lose up to 30% of their body weight, averaging 85 pounds.
- ▪The trial involved about 2,300 patients with obesity or who are overweight and lasted for 80 weeks.
- ▪Side effects included nausea, constipation, and diarrhea, common with GLP-1 drugs.
4 outlets in our directory ran this story, first to last over 33 hours. Coverage spans 3 points on the political spectrum — 1 lean left, 1 centre, 1 lean right.
- ▪ Is the End of the Obesity Epidemic Near? People Lost Up to 85 Pounds Using New Weight Loss Drug — Reason.com
- ▪ Lilly’s new experimental shot produced 28% weight loss — MarketWatch — Top Stories
- ▪ Experimental Drug Yields Dramatic Weight Loss — NYT > Top Stories
NBC News — Health files mainly under health. We currently carry 21 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | NBC News — Health |
| Canonical URL | https://www.nbcnews.com/health/health-news/people-lost-85-pounds-lillys-experimental-weight-loss-drug-company-say-rcna346172 |
| Publication time | Thu, 21 May 2026 10:45:00 GMT |
| Retrieval time | 2026-05-21T10:51:10.728Z |
| Last seen | 2026-05-21T10:51:10.728Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | 7hq_qh4jc-OV · 4 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Health newsPeople lost up to 85 pounds on Lilly’s experimental weight loss drug, company saysThe results — the most weight loss ever seen in a medication trial — put the drug’s effectiveness on par with bariatric surgery. Listen to this article with a free account00:0000:00Eli Lilly headquarters in Indianapolis. AJ Mast / Bloomberg via Getty Images file ShareAdd NBC News to GoogleMay 21, 2026, 6:45 AM EDTBy Berkeley Lovelace Jr.Eli Lilly’s highly anticipated new weight loss drug, retatrutide, helped people lose up to 30% of their body weight, about 85 pounds, in a late-stage clinical trial, the drugmaker said in a news release Thursday.Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content.The results are on par with bariatric surgery, which…
Excerpt limited to ~120 words for fair-use compliance. The full article is at NBC News — Health.
Discussion
0 commentsMore from NBC News — Health
